Literature DB >> 19384598

Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain.

Jean Lud Cadet1, Irina N Krasnova, Bruce Ladenheim, Ning-Sheng Cai, Michael T McCoy, Fidelis E Atianjoh.   

Abstract

Pretreatment with methamphetamine (METH) can attenuate toxicity due to acute METH challenges. The majority of previous reports have focused mainly on the effects of the drug on the striatal dopaminergic system. In the present study, we used a regimen that involves gradual increases in METH administration to rats in order to mimic progressively larger doses of the drug used by some human METH addicts. We found that this METH preconditioning was associated with complete protection against dopamine depletion caused by a METH challenge (5 mg/kg x 6 injections given 1 h apart) in the striatum and cortex. In contrast, there was no preconditioning-mediated protection against METH-induced serotonin depletion in the striatum and hippocampus, with some protection being observed in the cortex. There was also no protection against METH-induced norepinephrine (NE) depletion in the hippocampus. These results indicate that, in contrast to the present dogmas, there might be differences in the mechanisms involved in METH toxicity on monoaminergic systems in the rodent brain. Thus, chronic injections of METH might activate programs that protect against dopamine toxicity without influencing drug-induced pathological changes in serotoninergic systems. Further studies will need to evaluate the cellular and molecular bases for these differential responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384598      PMCID: PMC2673017          DOI: 10.1007/s12640-009-9026-0

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  48 in total

1.  Amphetamine abuse. Pattern and effects of high doses taken intravenously.

Authors:  J C Kramer; V S Fischman; D C Littlefield
Journal:  JAMA       Date:  1967-07-31       Impact factor: 56.272

2.  Hypothermic protection in rat focal ischemia models: strain differences and relevance to "reperfusion injury".

Authors:  Yubo Ren; Megumi Hashimoto; William A Pulsinelli; Thaddeus S Nowak
Journal:  J Cereb Blood Flow Metab       Date:  2004-01       Impact factor: 6.200

Review 3.  Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi; Xiaolin Deng
Journal:  FASEB J       Date:  2003-10       Impact factor: 5.191

4.  Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study.

Authors:  G A Ricaurte; C R Schuster; L S Seiden
Journal:  Brain Res       Date:  1980-07-07       Impact factor: 3.252

5.  The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity.

Authors:  Kamisha L Johnson-Davis; Annette E Fleckenstein; Diana G Wilkins
Journal:  Eur J Pharmacol       Date:  2003-12-15       Impact factor: 4.432

6.  Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons.

Authors:  Chia-Ho Lin; Po-See Chen; Po-Wu Gean
Journal:  Eur J Pharmacol       Date:  2008-06-06       Impact factor: 4.432

7.  Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.

Authors:  G A Ricaurte; R W Guillery; L S Seiden; C R Schuster; R Y Moore
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

8.  Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.

Authors:  Yoshimoto Sekine; Yoshio Minabe; Yasuomi Ouchi; Nori Takei; Masaomi Iyo; Kazuhiko Nakamura; Katsuaki Suzuki; Hideo Tsukada; Hiroyuki Okada; Etsuji Yoshikawa; Masami Futatsubashi; Norio Mori
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

9.  Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine.

Authors:  Kamisha L Johnson-Davis; Jannine G Truong; Annette E Fleckenstein; Diana G Wilkins
Journal:  J Pharmacol Exp Ther       Date:  2004-01-27       Impact factor: 4.030

10.  Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.

Authors:  Mary P Stenzel-Poore; Susan L Stevens; Zhigang Xiong; Nikola S Lessov; Christina A Harrington; Motomi Mori; Robert Meller; Holly L Rosenzweig; Eric Tobar; Tatyana E Shaw; Xiangping Chu; Roger P Simon
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

View more
  21 in total

1.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

Review 2.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

3.  Methamphetamine blunts Ca(2+) currents and excitatory synaptic transmission through D1/5 receptor-mediated mechanisms in the mouse medial prefrontal cortex.

Authors:  Betina González; Celeste Rivero-Echeto; Javier A Muñiz; Jean Lud Cadet; Edgar García-Rill; Francisco J Urbano; Verónica Bisagno
Journal:  Addict Biol       Date:  2015-04-14       Impact factor: 4.280

4.  Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Int J Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 5.176

5.  Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug.

Authors:  Jean Lud Cadet; Christie Brannock; Bruce Ladenheim; Michael T McCoy; Genevieve Beauvais; Amber B Hodges; Elin Lehrmann; William H Wood; Kevin G Becker; Irina N Krasnova
Journal:  Dose Response       Date:  2010-07-02       Impact factor: 2.658

6.  Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection.

Authors:  Michael T McCoy; Subramaniam Jayanthi; Jacqueline A Wulu; Genevieve Beauvais; Bruce Ladenheim; Tracey A Martin; Irina N Krasnova; Amber B Hodges; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2011-01-13       Impact factor: 4.530

Review 7.  Chronic methamphetamine self-administration disrupts cortical control of cognition.

Authors:  Aurelien Bernheim; Ronald E See; Carmela M Reichel
Journal:  Neurosci Biobehav Rev       Date:  2016-07-20       Impact factor: 8.989

8.  Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum.

Authors:  Jean Lud Cadet; Michael T McCoy; Ning Sheng Cai; Irina N Krasnova; Bruce Ladenheim; Genevieve Beauvais; Natascha Wilson; William Wood; Kevin G Becker; Amber B Hodges
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

9.  Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

Authors:  Irina N Krasnova; Zuzana Justinova; Bruce Ladenheim; Subramaniam Jayanthi; Michael T McCoy; Chanel Barnes; John E Warner; Steven R Goldberg; Jean Lud Cadet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.